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Although a great deal is known concerning the membrane events controlling Ca” 
influx and metabolism, the events triggered by Caz+ that lead to exocytosis in neurons 
and other cells are poorly understood. The purpose of this article is to consider some 
of the processes that control exocytosis, with special emphasis on the bovine adrenal 
chromaffin cell as a model system. Chromaffin cells are excitable cells and, like 
sympathetic nerves, are derived from the neural crest. Although chromaffin cells do 
not contain long processes or nerve terminals, secretion from chromaffin cells is 
stimulated by Ca’+ influx and inhibited by the clostridial neurotoxins (see below), 
which block exocytosis from the nerve terminals of peripheral and central nervous 
system neurons. Thus, it is likely that the secretory pathway in chromaffin cells is 
similar to that in neurons. Chromaffin cell secretory vesicles (chromaffin granules) 
are large, dense core vesicles that contain proteins, peptides, ATP, and the catechol- 
amines epinephrine and norepinephrine. Ca2+ influx is stimulated in bovine chro- 
maffin cells by activation of the nicotinic receptor/channel complex and voltage- 
sensitive Ca2+ channels. 
EXOCYTOSIS AND GTP-BINDING PROTEINS 
Exocytosis is the last fusion event in the repeated sequence of vesicle budding 
and fusion that characterizes the passage of secretory proteins from the endoplasmic 
reticulum to the cell exterior (for review see ref. 1). Secretory vesicles leaving the 
trans golgi network are targeted to different locations. Some vesicles are targeted to 
lysosomes. Some go quickly to the plasma membrane where exocytosis occurs in a 
seemingly unregulated manner (constitutive secretion).’ Other vesicles fuse with the 
plasma membrane in a highly regulated manner. In the neuron, regulated exocytosis 
can occur meters away from the cell body where synthesis of the secretory vesicle 
membrane and intravesicular proteins occurs. Secretory vesicles involved in synaptic 
transmission journey to the nerve terminal by way of a microtubule-based transport 
system. After fusion with the plasma membrane, vesicle membrane recycles by way of 
endocytosis. In the case of small synaptic vesicles that store nonprotein neurotrans- 
mitters (e.g., acetylcholine), the recycled vesicles are reused locally for exocytosis? 
In endocrine cells and nerve terminals, the events leading to fusion of the 
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secretory vesicle with the plasma membrane are highly regulated. In most cases a rise 
in cytosolic Ca2+ from 0.1 pM to micromolar or higher concentrations is the primary 
trigger for exocytosis. One of the major challenges in the study of the biochemistry of 
exocytosis is to distinguish those processes that are intimately involved in regulating 
exocytosis from the many processes activated by Ca2+. Although there are many 
possibilities (eg., protein phosphorylation, cytoskeletal changes, changes in lipid 
metabolism: see below), at this time we do not know the critical events activated by 
Caz+. An alternative approach is to consider whether regulated exocytosis in either 
endocrine cells or in nerve terminals has elements in common with the multiple 
fusion events occurring earlier in the biosynthetic pathway of secretory proteins. 
The genetic analysis of protein secretion in yeast led to the identification and 
purification of SEC4p, which is necessary for fusion of post-Golgi vesicles with the 
plasma membrane? and YPTlp, which is necessary for protein transfer from 
endoplasmic reticulum (ER) to GolgL6 Both SEC4p and YPTlp are 23 kDa, 
GTP-binding proteins homologous to the rus family of GTP-binding proteins. They 
share 45% homology with each other. GTP-binding proteins are involved in the 
transfer and fusion of vesicles formed from donor cisternae (ER or Golgi compart- 
ments) to subsequent cisternae in the eukaryotic biosynthetic pathway. A nonhydro- 
lyzable analogue of GTP (GTPyS) prevents transfer of protein from ER to Golgi,' 
and between Golgi compartments,* and induces the accumulation of coated vesicles 
in the Golgi region' and the accumulation of tubular-vesicular membranes near the 
ER. It has been postulated that GTP binding to vesicular protein and subsequent 
GTP hydrolysis are required for proper targeting and transfer of budding vesicles.1o 
An epitope in common with YPTlp is associated with mammalian Golgi.6 
Do low molecular weight, GTP-binding proteins generally play an important role 
in targeting secretory vesicles or controlling fusion in regulated exocytosis? At this 
time the answer is unclear. Both chromaffin granules, the secretory vesicles in 
adrenal chromaffin cells,231' and bovine brain synaptic  vesicle^'*^'^ contain numerous 
GTP-binding proteins between 20 and 30 kDa. FIGURE 1A demonstrates the 
multitude of these proteins that are found on secretory vesicles. One can distinguish 
at least six proteins on bovine chromaffin granule membranes and on bovine brain 
synaptic vesicles. (These brain synaptic vesicles display active glutamate ~ p t a k e . ' ~ ~ ' ~ )  
GTP-binding proteins from chromaffin granules and synaptic vesicles have identical 
mobilities in SDS-PAGE. A GTP-binding protein of approximately 45 kDa can also 
be detected that probably corresponds to either a. or ai, the pertussis toxin substrates 
for ADP-ribosylation that have been previously demonstrated on chromaffin gran- 
ules.I6 A quantitative analysis of GTP-binding sites on chromaffin granules (FIG. 1B) 
indicates that there are approximately 60 GTP-binding sites per chromaffin granule, 
which accounts for approximately 5% of the total granule membrane protein (see 
FIG. 1B legend). Nonhydrolyzable guanine nucleotides have a number of effects on 
secretion in permeabilized secretory cells. GTPyS inhibits Ca2+-dependent secretion 
from electropermeabilized bovine chromaffin cells when added together with CaZ+" 
and from digitonin-permeabilized bovine chromaffin cells when a low concentration 
of GTPyS is incubated with permeabilized cells prior to stimulation with Ca2+ (FIG. 
2). These effects are consistent with the effects of GTPyS to inhibit transfer and 
fusion of vesicles in earlier steps in the biosynthetic pathway of secretory proteins. 
The effects, however, depend upon cell type, method of plasma membrane perme- 
abilization and experimental design. For example, nonhydrolyzable guanine nucle- 
otides stimulate Ca*+-dependent secretion in electropermeabilized chicken chro- 
maffin cells'7 and in bovine chromaffin cells permeabilized by a-toxin.I8 Guanine 
nucleotides and Caz+ are required for secretion from streptolysin-0- or digitonin- 
permeabilized mast cells in the presence of high concentrations of Cl-.'9,20 When the 
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C1- concentration, however, is reduced" or when protein kinase C is activated:' 
either GTPyS or Ca" alone stimulates submaximal secretion. GTPyS also stimulates 
Ca2+-independent secretion from digitonin-permeabilized bovine chromaffin cells:'322 
and PC12 cells,23 and from mast cells using whole cell recording with the patch 
The multitude of effects of nonhydrolyzable guanine nucleotides on 
secretion is not surprising inasmuch as guanine nucleotides can activate a host of 
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FIGURE 1A. GTP-binding proteins associated with bovine chromaffin granules and bovine 
brain glutamatergic synaptic vesicles. Chromaffin granules were purified from fresh bovine 
adrenal medulla. Adrenal glands were homogenized in 0.29 M sucrose, 10 mM Hepes (pH 7.1), 
1 mM Na,EDTA, 1 mM PMSF, and chromaffin granules purified using a discontinuous sucrose 
gradient according to Smith and Winkler? except that the large granule fraction was layered 
over a 1.7 M sucrose solution. The gradient was centrifuged at 146,000 X g, x 70 min in a 
Beckman 50.2 Ti rotor. The chromaffin granules were collected in the pellet, lysed in 10 mM 
Hepes (pH 7.1), and washed twice and stored at -70. Synaptic vesicles were purified from 
bovine brain according to the methods of Ueda and  colleague^'^^'^ with an additional gel 
filtration step using Sephacryl 1000. The vesicle fraction concentrated glutamate in an ATP- 
dependent manner. The molecular masses of the GTP-binding proteins are 20.1 kDa, 22.4 kDa, 
23.0 kDa (dense band), 24.6 kDa, 26.5 kDa, 27.5 kDa, and 45 kDa. 
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FIGURE 1B. Specific GTPyS binding to chromaffin granule membranes. Purified chromaffin 
granules (2 pg/mL) were incubated with various concentrations of nonradioactive GTPyS and 
0.235 nM ["SIGTPyS (0.23 pC,/mL) for 90 min at 30°C. The suspension was passed through a 
nitrocellulose filter. The filter was washed extensively and the radioactivity determit~ed.'~ The 
data were analyzed by a nonlinear, least squares algorithm. Assuming a chromaffin granule 
diameter of 2800 angstroms, 17 FL chromaffin granule volume/mg membrane protein and 
maximal binding of 194 pmoles/mg membrane protein, one calculates 78 GTPyS binding 
sitedchromaffin granule. A similar experiment using a different preparation of granules yielded 
130 pmoles GTPyS binding/mg membrane protein and 52 GTPyS binding siteslchromaffin 
granule. Approximately 4 6 %  of the total chromaffin granule membrane protein is GTP- 
binding protein, assuming an average molecular mass of 30 kDa for GTP-binding proteins. 
enzymes either directly or indirectly (e.g., adenylate cyclase, phospholipase C, 
phospholipase A,, protein kinase C) that could influence the secretory response. 
Thus, it is unclear which, if any, of the effects of guanine nucleotides on secretion 
requires GTP-binding proteins on secretory vesicles. Furthermore, it is possible that 
the GTP-binding proteins associated with secretory vesicles are not directly involved 
in secretion but with other functions of the vesicles related to biosynthesis of the 
membrane" or recycling after exocytosis. 
THE ROLE OF ATP IN SECRETION PRIMING OF SECRETION, PROTEIN 
PHOSPHORYLATION, AND MAINTENANCE OF 
POLYPHOSPHOINOSITIDES 
Experiments with permeabilized chromaffin cells by Baker and KnightZ8zZ9 conclu- 
sively demonstrated a role for ATP hydrolysis in the intracellular pathway for 
exocytosis. Synaptic transmission occurs within less than a millisecond after invasion 
of the terminal by the action potential and the opening of voltage-sensitive Caz+ 
channels. Because this is insufficient time for a cascade of biochemical  reaction^,'^ 
the exocytotic machinary must be poised to respond rapidly to the rise in Ca2+. In 
experiments with the patch clamp in which incorporation of the granule membrane 
into the plasma membrane is measured by increases in plasma-membrane capaci- 
tance, depolarization-induced secretion from chromaffin cells occurs within the time 
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FIGURE 2. GTPyS inhibits secretion from digitonin-permeabilized chromaffin cells. ['Hlnor- 
epinephrine-labeled chromaffin cells were permeabilized by incubation in KGEP [ 139 mM 
potassium glutamate, 5 mM EGTA, 20 mM PIPES (pH 6.6), 1 mM MgCI,, and 5 mg/mL BSA] 
containing 2 mM MgATP, 20 p,M digitonin, and various concentrations of GTPyS. After 4 min, 
the solution was replaced with digitonin-free KGEP without MgATP and GTPyS, and with and 
without 10 FM free Ca2+. Caz+-dependent secretion was determined after 2 min. Secretion in 
the absence of Ca2+ was 1.6-2.4%. GTPyS at all concentrations released less than 1% of the 
catecholamine during the incubation with digitonin. There were 3 wellsigroup. 
FIGURE 3. The phorbol es- 
ter TPA enhances secretion 
from digi tonin-perme- 
abilized chromaffin cells. 
[3H]norepinephrine-labeled 
cells were incubated for 30 
min in MEM with or with- 
out 20 nM TPA. The cells 
were permeabilized in 
KGEP containing 2 mM 
MgATP with indicated 
[Ca'+]. Ca2'-dependent se- 
cretion was determined af- 
ter 15 min. Secretion in the 
absence of Caz+ was 3.4- 
3.6%. There were 3 wells/ 
group. 
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FIGURE 4. The protein kinase C inhibitor pep- 
tide PKC( 19-31) inhibits Ca2+-dependent secre- 
tion in TPA-treated but not in TPA-untreated 
chromaffin cells. [“Hlnorepinephrine-labeled cells 
were incubated for 15 rnin with (filled circles) or 
without (unfilled circles) 60 nM TPA in physiolog- 
ical salt solution. Cells were permeabilized for 6 
min in Ca2+-free potassium glutamate solution 
(KGEP) containing 20 pM digitonin in the pres- 
ence or absence of increasing concentrations of 
PKC(19-31). The solution was replaced with 
KGEP with or without 1 pM Ca2+ in the continu- 
ing presence or absence of PKC(19-31). Ca2+- 
dependent secretion was measured after 5 min. 
Release in the absence of Ca2+ was 3 .144%.  
There were 3 we l l~ /g roup .~~  0%- 
[PKC(19-31)] log(M) 
resolution of the experiments (several hundred  millisecond^).^^ In experiments in 
which release of catecholamine is detected biochemically, the maximal rate of 
secretion occurs within the first 1-2 min and then slows32; secretion can be reproduc- 
ibly detected within 10 We found that the rapid initial rate of catechol- 
amine secretion requires prior incubation with ATP.32 Although the time scale of the 
experiments is orders of magnitude slower than the events following Ca2+ entry in the 
nerve terminal, the experiments nevertheless demonstrate that ATP acts before Ca2+ 
to prime the cell to respond to Ca2+. A similar conclusion can be drawn from 
experiments with mast cells.34 
ATP is required for protein phosphorylation, and there is abundant evidence that 
protein phosphorylation modulates exocytosis. In the squid giant synapse3’ and 
mammalian synapto~omes~~ Ca/calmodulin kinase I1 enhances secretion, perhaps by 
MgATP D.R. 0 
PI-PLC D.R. 0 
0 250 500 750 1000 
PIP + PIP2 (cpm) 
FIGURE 5. The relationship between the levels of 
the polyphosphoinositides and Ca2+-dependent secre- 
tion in digitonin-permeabilized chromaffin cells. The 
polyphosphoinositides were varied in digitonin- 
permeabilized cells by varying the concentrations of 
MgATP or by varying the concentrations of a PtdIns- 
specific phospholipase C from Bacillus thuringiensis. 
[3H]Inositol-labeled cells were permeabilized for 8 
min in Ca2+-free potassium glutamate solution 
(KGEP) containing either various amounts of 
MgATP or 2 mM MgATP and various amounts of 
bacterial phospholipase C. The levels of [3H]inositol- 
labeled PtdIns, PtdInsP, and PtdInsP, were deter- 
mined after an additional 3 min incubation in 10 pM 
Ca2+ in the continuing presence of MgATP. Bacterial 
phospholpase C was not present in the last incuba- 
tion. Cazt-dependent secretion from [3H]norepineph- 
rine-labeled cells was determined in parallel experi- 
ments at 6 min. For details see FIG. 5 in ref. 45. 
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phosphorylation of synapsin I. In many secretory cells including chromaffin cells, 
activation of protein kinase C increases the ability of cells to respond to submicromo- 
lar and micromolar Caz+?7-39 FIGURE 3 demonstrates effects of the protein kinase C 
activator TPA (12-0-tetradecanoylphorbol acetate) on the Ca” dose-response 
relation for secretion from permeabilized cells. Because cellular protein kinase C can 
be activated by Ca2+ in the absence of exogenous  activator^,"^^^ an important issue is 
whether protein kinase C is required for secretion and is responsible for the ATP 
dependency. We have recently addressed this issue in permeabilized chromaffin cells 
using a specific inhibitor of protein kinase C. The synthetic peptide PKC(19-31), 
which is derived from the pseudosubstrate sequence of protein kinase C, is a potent 
inhibitor of protein kinase C in vitro4* and in situ within permeabilized 
Although it inhibited phorbol ester-induced secretion in the presence of Caz+ almost 
completely, it had no effect on Ca2+-dependent secretion in the absence of phorbol 
ester (FIG. 4). Thus, it is unlikely that the ATP-dependency for secretion reflects the 
necessary involvement of protein kinase C in the secretory pathway. Similarly, it is 
unlikely that calmodulin-dependent protein kinase or other calmodulin-dependent 
processes play a necessary role in secretion from permeabilized cells. Relatively high 
concentrations of the calmodulin antagonists trifluoperazine and calmidazolium 
have either partial effects in electropermeabilized chromaffin cells29.43 or virtually no 
effects in digitonin-permeabilized chromaffin cells (Holz, unpublished observations). 
Furthermore, an anticalmodulin antibody (Holz, unpublished observations) and a 
calmodulin-binding peptide4’ have no effect on secretion from digitonin-perme- 
abilized chromaffin cells. The ability of an anticalmodulin antibody to inhibit 
secretion when injected into intact cells44 may reflect a role for calmodulin in the 
events leading to a rise in cytosolic Ca2+. 
These data led us to consider other reactions in which ATP may be involved. We 
found that the maintenance of the polyphosphoinositides by PI and PIP kinases 
occurred over the same MgATP concentration range as that necessary to maintain 
exo~ytosis.~~ We also found that in the presence of MgATP we could manipulate the 
levels of the polyphosphoinositides by a bacterial phospholipase C that hydrolyzed 
their precursor, phosphatidylinositol. The polyphosphoinositides declined because 
of the action of endogenous lipid phosphatases in the absence of continued synthesis. 
The relationship between Ca2+-dependent secretion and the polyphosphoinositides 
was the same whether the lipids were manipulated by varying the MgATP concentra- 
tion or by varying the concentration of the bacterial phospholipase C (FIGURES 5 and 
6). The inhibitory effects of the exogenous phospholipase C could not be explained 
by the products of the bacterial phospholipase C reaction (IP, and diacylglycerol) or 
the loss of products from the endogenous phospholipase C (due to the loss of the 
polyphosphoinositide substrates). The simplest and most compelling interpretation 
is that the polyphosphoinositides are necessary in the secretory pathway. Thus, ATP 
FIGURE 6. Polyphosphoinositide metabolism in chromaffin cells. The polyphosphoinositides 
are synthesized from phosphatidylinositol by PI and PIP kinases. In resting cells, PIP, 
phosphatase and PIP phosphatase are responsible for degrading the polyphosphoinositides. 
Phospholipase C activated by receptor-mediated mechanisms or by a rise in cytosolic Ca2+” 
breaks down PIP, to IP, and diacylglycerol (not shown), Experiments in which the polyphospho- 
inositides are decreased by ATP or by hydrolysis of PI with a bacterial phospholipase C 
demonstrate a close correlation between the levels of the polyphosphoinositides and Ca2+- 
dependent secretion.“ Thus, reducing either substrate for PI kinase reduces the polyphospho- 
inositides and Caz+-dependent secretion. The requirement for the polyphosphoinositides in 
secretion could reflect the importance of a protein that binds to and is regulated by these lipids. 
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is important not only for modulation of secretion by protein kinases, but also for 
maintenance of the polyphosphoinositides. 
Polyphosphoinositides are synthesized both on the plasma membrane*’ and on 
the chromaffin granule membrane48-5” (FIG. 6). The binding of a protein to PIP, 
(and/or PIP) on either membrane may regulate its function in secretion. There are at 
least two proteins, myosin I and gelsolin, that bind to the polyphosphoinositides and 
to actin. Myosin I, which causes actin-dependent organelle movement, has recently 
been demonstrated to bind to PIP,?’ The ability of gelsolin to cause Ca*’-dependent 
severing of f-actin is inhibited by polyphosphoinositides” (for review see 53). Because 
chromaffin granules also interact with f-a~tin,’”’~ it is possible that the PIP, or PIP 
localizes these proteins to secretory sites and controls the interaction of chromaffin 
granules with the cortical cytoskeleton and the plasma membrane. In addition, 
calpactin I, which interacts with acidic phospholipids including the polyphosphoinosit- 
ides:7 aggregates and under some conditions allows fusion of chromaffin granules in 
v i t r ~ . ~ ~ ~ ’ ~  Indeed, recent reports suggest that calpactin is in intimate contact with 
chromaffin granules, and the plasma membrane in intact cells,“ and can maintain 
secretion in digitonin-permeabilized chromaffin cells.6136z 
CLOSTRIDIAL NEUROTOXINS DIRECTLY INHIBIT THE 
EXOCYTOTIC PATHWAY 
Botulinum and tetanus neurotoxins (clostridial neurotoxins) block neurotransmit- 
ter release from various neurons and are thought to interact with critical sites in the 
exocytotic pathway.63 Botulinum type D neurotoxin interacts with bovine tissues and 
inhibits secretion from both intact and electropermeabilized bovine chromaffin 
cells.64 Extracellular application of botulinum types A, B, or E neurotoxin or tetanus 
neurotoxin has no effect on intact bovine chromaffin cells because of the absence of 
receptors on the plasma membrane. The introduction of these toxins, however, into 
cells through a patch-clamp electrode6’ or by incubation with digitonin- or streptol- 
ysin 0 (SL-0)-permeabilized inhibits secretion. Experiments with permeabi- 
lized cells demonstrate that the light chain (50 kDa) of the dichain molecules (150 
kDa) is responsible for the inhibition of The ability of these classical 
inhibitors of synaptic transmission to inhibit exocytosis from chromaffin cells indi- 
cates that there are common elements in the secretory pathway in neurons and 
chromaffin cells. The toxins decrease the maximal extent of secretion and not the 
sensitivity to CaZt.66,67 Interestingly, the toxins do not all act alike. Both tetanus toxin 
and botulinum B neurotoxins completely inhibit secretion, whereas botulinum A 
neurotoxin, even at high concentrations, inhibits secretion by no more than 70 
percent. Thus, the toxins may interact with different sites in the secretory pathway. 
At the intact neuromuscular junction, the effects of tetanus and botulinum B 
neurotoxins can also be distinguished from those of botulinum A neurotoxin. 
Tetanus and botulinum B neurotoxins reduce evoked miniature end-plate potentials 
(MEPPS) and desynchronize those MEPPS that are observed.’l Botulinum A 
neurotoxin also reduces evoked MEPPS but without desynchronizing the residual 
MEPPS. Key issues for future investigation are the sites of interaction of the light 
chains of these toxins within nerve terminals and chromaffin cells and the possibility 
that they may act through an unknown enzymatic activity. The ADP-ribosylating 
activity of neurotoxin preparations is likely to be caused by contaminating ADP- 
ribosyl transferase activity (C-3 toxin)..’, 
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